Drugs / LX103
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05814952 | Dec 2022 → Aug 2024 overdue | X-linked retinoschisis | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LX103 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05814952 ↗ |
| Route | Intravitreal | “single unilateral intravitreal (IVT) injection of LX103” NCT05814952 ↗ |